Neogen Corporation Other Current Liabilities
Neogen Corporation (NEOG) had Other Current Liabilities of $23.90 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-07-30
- 2026-05-31: Other Liabilities, Current $23.90M.
- 2026-02-28: Other Liabilities, Current $28.20M.
- 2025-11-30: Other Liabilities, Current $30.77M.
- 2025-08-31: Other Liabilities, Current $30.51M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-05-31 | $23.90M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $28.20M 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $30.77M 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $30.51M 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $32.10M 10-K · filed 2026-07-30 | $32.18M 10-K · filed 2025-07-30 |
| 2025-02-28 | $25.99M 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $24.65M 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $22.48M 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $22.80M 10-K · filed 2025-07-30 | |
| 2023-05-31 | $20.93M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |